Selective cyclooxygenase-2 inhibitors: Hope and facts

Joint Bone Spine

Volumn 67, Issue 6, 2000, Pages 499-501

  Berenbaum, Francis ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ANALGESIA; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG SELECTIVITY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0034543559     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(00)00221-9     Document Type: Editorial

References (2)

1. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial
2. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases